Literature DB >> 20375708

(18)F-fluoro-L-thymidine-PET for the evaluation of primary brain tumours in children: a report of three cases.

Rozemarie Gilles1, Wouter V Vogel, Corrie E M Gidding, Geert O R J Janssens, Ton M van der Vliet, Wim J G Oyen.   

Abstract

BACKGROUND: F-fluoro-L-thymidine (FLT) has been shown to be a useful PET tracer in the evaluation of brain tumours in adults. No studies of this modality in children with brain tumours, however, have been published.
OBJECTIVE: In this report three children with brain tumours are presented in which FLT-PET was used for different diagnostic purposes, in addition to imaging with MRI and F-fluorodeoxyglucose-PET. The first patient showed that FLT-PET could be helpful in differentiating between infection and malignancy. In the second patient FLT-PET was used for differentiating recurrent disease from radiotherapy effects. In the third patient, in which biopsy was not possible, FLT-PET was used for the characterization of the tumour.
CONCLUSION: These patients show that FLT-PET might be a useful modality in different stages of the evaluation of primary brain tumours in children. However, further research to determine the clinical value, relative to MRI and fluorodeoxyglucose-PET, is required before routine implementation of FLT-PET.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375708     DOI: 10.1097/MNM.0b013e328318dc18

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  1 in total

1.  A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma.

Authors:  Danny L Costantini; Reza Vali; Susan McQuattie; Jeffrey Chan; Angela Punnett; Shiela Weitzman; Amer Shammas; Martin Charron
Journal:  Int J Mol Imaging       Date:  2016-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.